HUP9904045A2 - Progeszteron alkalmazása iszkémia kezelésére vagy enyhítésére - Google Patents

Progeszteron alkalmazása iszkémia kezelésére vagy enyhítésére

Info

Publication number
HUP9904045A2
HUP9904045A2 HU9904045A HUP9904045A HUP9904045A2 HU P9904045 A2 HUP9904045 A2 HU P9904045A2 HU 9904045 A HU9904045 A HU 9904045A HU P9904045 A HUP9904045 A HU P9904045A HU P9904045 A2 HUP9904045 A2 HU P9904045A2
Authority
HU
Hungary
Prior art keywords
progesterone
treating
ischemia
reducing ischemia
reducing
Prior art date
Application number
HU9904045A
Other languages
English (en)
Inventor
William J. Bologna
Howard Leslie Levine
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9904045(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of HUP9904045A2 publication Critical patent/HUP9904045A2/hu
Publication of HUP9904045A3 publication Critical patent/HUP9904045A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány prőgeszterőn alkalmazására vőnatkőzik iszkémia,szívkőszőrúér-betegség vagy kardiővaszkűláris események fellépésénekkezelésére vagy csökkentésére alkalmas gyógyszer előállítására. Aprőgeszterőn a szintetikűs prőgesztinektől eltérően nem csökkenti,hanem kiegészíti a nőkben miőkardiális iszkémia kezelésére alkalmazőttösztrőgén terápia előnyös hatásait. ŕ
HU9904045A 1996-11-04 1997-11-04 Progesterone for treating or reducing ischemia HUP9904045A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia

Publications (2)

Publication Number Publication Date
HUP9904045A2 true HUP9904045A2 (hu) 2000-04-28
HUP9904045A3 HUP9904045A3 (en) 2000-11-28

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904045A HUP9904045A3 (en) 1996-11-04 1997-11-04 Progesterone for treating or reducing ischemia

Country Status (27)

Country Link
US (2) US5985861A (hu)
EP (1) EP0956023B1 (hu)
KR (1) KR100434623B1 (hu)
CN (1) CN100341512C (hu)
AR (1) AR009407A1 (hu)
AT (1) ATE321558T1 (hu)
AU (1) AU715740C (hu)
BR (1) BR9710918A (hu)
CA (1) CA2270565C (hu)
DE (1) DE69735598T2 (hu)
DK (1) DK0956023T3 (hu)
ES (1) ES2262196T3 (hu)
GE (1) GEP20022630B (hu)
HK (1) HK1020534A1 (hu)
HU (1) HUP9904045A3 (hu)
IL (1) IL127455A (hu)
LV (1) LV12342B (hu)
MA (1) MA24391A1 (hu)
MY (1) MY121627A (hu)
NO (1) NO324278B1 (hu)
NZ (1) NZ335306A (hu)
PE (1) PE9899A1 (hu)
PT (1) PT956023E (hu)
RO (1) RO120607B1 (hu)
UA (1) UA66772C2 (hu)
WO (1) WO1998019681A1 (hu)
ZA (1) ZA979862B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (de) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Scheibenwaschvorrichtung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
SI2359807T1 (sl) 2008-02-04 2017-10-30 Ferring B.V. Monolitni intravaginalni obroč, ki vsebuje progesteron ter postopki za njegovo izdelavo in uporabo
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
JP2021535183A (ja) 2018-09-07 2021-12-16 トラスティーズ・オヴ・ダートマス・カレッジ Ｃ１９骨格およびステロイドならびにそれらの使用および製造方法
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (ru) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Способ коррекции ишемических повреждений консервированной донорской почки
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
ZA979862B (en) 1998-05-25
US6054447A (en) 2000-04-25
US5985861A (en) 1999-11-16
LV12342A (lv) 1999-09-20
AU715740C (en) 2004-04-29
AU5180198A (en) 1998-05-29
EP0956023B1 (en) 2006-03-29
KR20000053056A (ko) 2000-08-25
MA24391A1 (fr) 1998-07-01
CA2270565A1 (en) 1998-05-14
IL127455A (en) 2005-03-20
CN100341512C (zh) 2007-10-10
PE9899A1 (es) 1999-02-08
NO992140L (no) 1999-05-04
HUP9904045A3 (en) 2000-11-28
NO992140D0 (no) 1999-05-03
ES2262196T3 (es) 2006-11-16
IL127455A0 (en) 1999-10-28
NZ335306A (en) 2000-12-22
DE69735598D1 (de) 2006-05-18
NO324278B1 (no) 2007-09-17
GEP20022630B (en) 2002-02-25
RO120607B1 (ro) 2006-05-30
LV12342B (en) 2000-01-20
ATE321558T1 (de) 2006-04-15
EP0956023A1 (en) 1999-11-17
BR9710918A (pt) 2000-01-11
DK0956023T3 (da) 2006-08-07
DE69735598T2 (de) 2006-12-28
AU715740B2 (en) 2000-02-10
MY121627A (en) 2006-02-28
KR100434623B1 (ko) 2004-06-05
WO1998019681A1 (en) 1998-05-14
HK1020534A1 (en) 2000-05-12
CN1235549A (zh) 1999-11-17
AR009407A1 (es) 2000-04-12
PT956023E (pt) 2006-08-31
UA66772C2 (uk) 2004-06-15
CA2270565C (en) 2007-02-20

Similar Documents

Publication Publication Date Title
HUP9904045A2 (hu) Progeszteron alkalmazása iszkémia kezelésére vagy enyhítésére
EP1319404A3 (de) Mittel zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
EP1014996A4 (en) SACCHARIDE COMPOSITIONS AND METHODS FOR SPECIFIC TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSIS
PL316533A1 (en) Progesterone antagonists used for producing therapeutic agents useful in treating dysfunctional metrorrhagiae
BG101349A (en) Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
EP0407008A3 (en) Fibronectin fragment
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
AU6256996A (en) Use of vitamin D4 derivatives for treating skin disorders
CA2200480A1 (en) New use of prostaglandins
GR3020419T3 (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
DE69636814D1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma
BR9713828A (pt) Tratamento de tumores altamente vasculares
CA2306772A1 (en) Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
MY107336A (en) The process for the preparation of enantiomerically pure thienopyran derivatives.
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
ES2148057A1 (es) Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3
IT1286182B1 (it) Impiego della relaxina o relassina, come nuovo agente farmacologico antistaminico per bloccare il rilascio di istamina nei tessuti in
IT1286183B1 (it) Uso della relaxina come agente farmacologico per la produzione di farmaci per la cura delle gestosi gravidiche
UA79424C2 (en) Use of fsh for treatment of infertility in women
MD950121A (ro) Metodă de tratare a urmărilor ictusurilor ischemice